Abstract 1728P
Background
The prevalence of oncology survivors is increasing exponentially. More than half of them experience difficulty in returning to their pre-disease socio-familial role. Comprehensive Oncology Units are infrequent in our environment. In our center we have implemented this novel Unit in order to improve the quality of life of our cancer survivors during follow-up.
Methods
Prospective quasi-experimental study. From March 2022 to March 2023. A total of 232 patients were included in the Comprehensive Oncology Unit of the Juan Ramón Jiménez Hospital in Huelva. The aim of our study is to describe the psychosocial, nutritional and physical needs of cancer survivors during follow-up and the impact of the intervention on their quality of life.
Results
The median age of the patients was 53 years (33 - 78). Ninety-six percent were women. Ninety percent had been diagnosed with breast cancer, followed by 6 % CRC, 2 % other digestive tumors and 2 % gynecological tumors. 67.1% required assessment for nutrition, 62.9% for rehabilitation, 59.28% for psycho-oncology and 4.8% for social intervention. Of the patients who were evaluated by psycho-oncology, 50% improved their fear of recurrence with only 3 sessions. Regarding nutrition assessment, the median BMI in the population with BMI > 25kg/m2 was 30.7 Kg/m2 at baseline and 29.71 Kg/m2 (22.7 - 40) 6 months after nutrition intervention (p<0.001).
Conclusions
The results of our study reveal that there is a high demand of needs to be covered in cancer survivors beyond the purely clinical aspects that impact on their quality of life. Implementing a Comprehensive Oncology Unit could help to detect these needs and improve their healthy lifestyle habits as well as improve their quality of life.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Comprehensive Oncology Unit.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1726P - Optimizing oncology drug spending in a cancer centre in Ireland
Presenter: Ruth Kieran
Session: Poster session 23
1727P - Barriers and facilitators of physician involvement in clinical oncology database management in Ukraine
Presenter: Inesa Huivaniuk
Session: Poster session 23
1729P - Targeted interventions in registration and reporting of multidisciplinary team meetings (MDT) in oncology help to improve tumor board decisions
Presenter: Lars Galonska
Session: Poster session 23
1730P - Dealing with digital paralysis: Surviving a cyberattack in a cancer centre
Presenter: Rachel J. Keogh
Session: Poster session 23
1731P - Providing access to anticancer drugs within an armed conflict: The experience of Mission Kharkiv (MK) and Medecins Sans Frontieres (MSF) in Ukraine
Presenter: Stanislav Polozov
Session: Poster session 23
1732P - War and the fragility of anticancer drug supply networks in Ukraine
Presenter: Olha Kostenchak-Svystak
Session: Poster session 23
1733P - Two wars at time: Fight against cancer during war time - experience of Ukraine
Presenter: Veronika Patsko
Session: Poster session 23
1734P - Early impact of a personalized lung cancer interception program for heavy smokers
Presenter: Pamela Abdayem
Session: Poster session 23
1735P - Impact of revised US Preventive Services Task Force (USPSTF) 2021 lung cancer screening guideline on long-term cancer survivors in the United States
Presenter: Qian Wang
Session: Poster session 23
1736P - Young adult lung cancer demands more attention in a low-resource area: Bangladesh perspective
Presenter: Muhammad Rafiqul Islam
Session: Poster session 23